Latent Tuberculosis Infection Detection Market

The global Latent Tuberculosis Infection Detection market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
The main ways to diagnose LTBI are by�placing a tuberculin skin test (TST) on the forearm or by getting a TB blood test, in addition to obtaining a chest radiograph (x-ray) if either one of these tests is positive. One-third of the world"s population has LTBI. The TB germs are dormant (asleep) in the body.
The U.S. market is estimated at $ million in 2024, while China is to reach $ million.
Tuberculin Skin Test segment will reach $ million by 2032, with a % CAGR in next six years.
The global key players of Latent Tuberculosis Infection Detection include Abbott, QIAGEN, F. Hoffmann-La Roche Ltd, Sanofi, Oxford Immunotec USA, ARKRAY, Inc., bioM�rieux SA, etc. In 2024, the global top five players had a share approximately % in terms of revenue.
We have surveyed the Latent Tuberculosis Infection Detection companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
Latent Tuberculosis Infection Detection Market aims to provide a comprehensive presentation of the global market for Latent Tuberculosis Infection Detection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Latent Tuberculosis Infection Detection. Latent Tuberculosis Infection Detection Market contains market size and forecasts of Latent Tuberculosis Infection Detection in global, including the following market information:
Global Latent Tuberculosis Infection Detection market revenue, 2020-2025, 2026-2032, ($ millions)
Global top five Latent Tuberculosis Infection Detection companies in 2024 (%)
Total Market by Segment:
Global Latent Tuberculosis Infection Detection market, by Type, 2020-2025, 2026-2032 ($ millions)
Global Latent Tuberculosis Infection Detection market segment percentages, by Type, 2024 (%)
Tuberculin Skin Test
Interferon Gamma Release Assays
Global Latent Tuberculosis Infection Detection market, by Application, 2020-2025, 2026-2032 ($ millions)
Global Latent Tuberculosis Infection Detection market segment percentages, by Application, 2024 (%)
Diagnostic Laboratories
Hospitals/Clinics
Academic & Research Institutions
Global Latent Tuberculosis Infection Detection market, by region and country, 2020-2025, 2026-2032 ($ millions)
Global Latent Tuberculosis Infection Detection market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Latent Tuberculosis Infection Detection revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Latent Tuberculosis Infection Detection revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
QIAGEN
F. Hoffmann-La Roche Ltd
Sanofi
Oxford Immunotec USA
ARKRAY, Inc.
bioM�rieux SA
Outline of Major Chapters:
Chapter 1: Introduces the definition of Latent Tuberculosis Infection Detection, market overview.
Chapter 2: Global Latent Tuberculosis Infection Detection market size in revenue.
Chapter 3: Detailed analysis of Latent Tuberculosis Infection Detection company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Latent Tuberculosis Infection Detection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.